NeuroDerm (NDRM) Misses Q2 EPS by 12c

August 25, 2016 7:27 AM EDT
Get Alerts NDRM Hot Sheet
Trade NDRM Now!
Join SI Premium – FREE

News and research before you hear about it on CNBC and others. Claim your 2-week free trial to StreetInsider Premium here.

NeuroDerm (NASDAQ: NDRM) reported Q2 EPS of ($0.44), $0.12 worse than the analyst estimate of ($0.32).

As of June 30, 2016, the Company had cash and cash equivalents and short-term bank deposits totaling $89.8 million.

For earnings history and earnings-related data on NeuroDerm (NDRM) click here.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In






Related Categories

Earnings

Related Entities

Earnings

Add Your Comment